CD8+ T cells are important for immunity against human cytomegalovirus (HCMV). The
HCMV-specific CD8
IntroductionUpon viral infection the immune system engages lymphocytes such as NK cells, CD4 + and CD8 + T cells to eliminate the virus.
CD4+ and CD8 + T cells recognize viral peptides presented by MHC class II (MHC-II) and MHC class I (MHC-I) molecules respectively. CD8 + T cells specific for the infecting pathogen first undergo massive expansion before they differentiate into cytotoxic cells capable of producing high levels of effector molecules such as IL-2, IFN-γ, TNF-α, perforin and granzyme B [1, 2]. Naïve CD4 + T cells alsoCorrespondence: Dr. Klaas P. J. M. van Gisbergen e-mail: k.vangisbergen@sanquin.nl expand and develop an effector (Th1) phenotype capable of secreting copious amounts of IFN-γ, IL-2 and TNF-α to assist CD8 + T-cell and B-cell responses [3]. To avoid T-cell detection and lysis of the infected cells, viruses of the Herpesviridae family including human cytomegalovirus (HCMV) have evolved mechanisms to downregulate MHC-I molecules on infected cells [4,5]. In turn, NK cells can detect downregulation of MHC expression and produce inflammatory cytokines such as IFN-γ, TNF-α, and cytotoxic granules containing effector molecules, such as perforin and the serine protease granzyme B, to eliminate infected cells [6,7]. HCMV is a member of the Herpesviridae family of doublestranded DNA viruses and has coevolved with humans for millions of years [8]. HCMV has a broad tropism for a wide range of tissues including endothelium, fibroblasts, smooth muscle, and C 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu 2434 Felipe A. Vieira Braga et al. Eur. J. Immunol. 2015. 45: 2433-2445 hematopoietic cells. HCMV is a prevalent human pathogen, with 40-70% of the western population being seropositive for HCMV [9]. HCMV induces persistent infection, which can be divided into acute and latent phases, and which are respectively characterized by active replication and quiescence of the virus [10]. The majority of HCMV-infected individuals do not develop any symptoms, but immunocompromised individuals, such as transplant recipients and HIV + patients, are a risk group for HCMV infection and can present with symptoms such as vascular complications [8].In order to follow T-cell responses in humans, we and others have made extensive use of instances of primary HCMV infection of transplant patients, which occurs when an HCMV − recipient receives an organ transplant from an HCMV + donor. Using this system, the data show that the initial early T-cell response against HCMV peaks on average 7 days after the first detection of circulating CMV-DNA. The T-cell response is initially dominated by CD4 + T cells that have a T-helper 1 type cytokine signature, with high production of the cytokines IFN-γ and TNF-α, but not of the classical T-helper 2 cytokine . A few days after the initial CD4 + T-cell response, HCMV-specific CD8 + T cells with high cytotoxic potential can be detected in blood. Remarkably, after th...